| Chajuta Guss, MD | |
|
1001 6th Ave, Suite 320, Leavenworth, KS 66048-3222 | |
| (913) 682-7705 | |
| Not Available |
| Full Name | Chajuta Guss |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 48 Years |
| Location | 1001 6th Ave, Leavenworth, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639162696 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 22450 (Kansas) | Primary |
| 207K00000X | Allergy & Immunology | R-1-J09 (Missouri) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Chajuta Guss, MD Po Box 12030, Overland Park, KS 66282-2030 Ph: (913) 381-9260 | Chajuta Guss, MD 1001 6th Ave, Suite 320, Leavenworth, KS 66048-3222 Ph: (913) 682-7705 |
News Archive
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is establishing four new Research Units. The decision was made by the DFG Senate at its December session in Bonn. The establishment of the Research Units will enable researchers to explore prevailing topical questions and generate new approaches in their respective fields.
Ex-prisoners with a history of risky drug use, mental illness or poverty are more likely to end up back behind bars. Those who are obese, are chronically ill or have attempted suicide are more likely to remain in the community. These are some of the findings from an exploratory study into health-related factors that could be used to predict whether a person released from prison will end up in custody again.
Researchers from the Federal Research and Clinical Centre of Physical-Chemical Medicine, and staff from MIPT's Systems Biology Laboratory, the Research Institute of Phthisiopulmonology and the St. Petersburg Pasteur Institute, conducted a large-scale analysis of the proteins and genomes of mycobacterium tuberculosis strains that are common in Russia and countries of the former Soviet Union and found features that provide a possible explanation for their epidemiological success.
An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.
› Verified 8 days ago
Salomon L Guss, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 1001 6th Ave, Suite 320, Leavenworth, KS 66048 Phone: 913-682-7705 |